Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PXMD PaxMedica > Key Indicators
PXMD PaxMedica
2.119
-0.261-10.97%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
ROA
92.38% -85.414% -- 795.918% -- -323.373% 28.71% -1154.192%
Efficiency Ratios
Profitability Ratios TTM
Financial Health Ratios
Total Assets to Common Equity
-- 250.379% -- -- -- -- -- --
Debt to Asset Ratio
-- 6.552% -- -- -- -- -- --
Current Ratio
1,605.78% 1.665 -- 0.0011 -- 0.0057 -78.87% 0.0413
Quick Ratio
1,486.99% 1.549 -- 0.0011 -- 0.0057 -78.87% 0.0413
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.
CEO: Mr. Howard J. Weisman
Market: NASDAQ
Listing Date: 08/26/2022
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist